rewirebio.iobenchmarks
Dataset

BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing

BRCA1 missense variants with a functional class, as assembled by Cubuk et al. 2021.

Research readiness

These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.

Release 2026-10-10-84341e0b121f · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • metric replay: verification is missing

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • metric replay: verification is missing
  • annotations: verification is missing
  • dependence: verification is missing

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • recipe pinned: verification is missing
  • resource estimate: verification is missing

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • independent validation: verification is missing
  • overlap checked: verification is missing

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Read reviewed discrepancy investigations

Evaluation results

84 evaluations · 247 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: alignGVGD_a (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
2.61 benignity-likelihood-ratio
unitless · higher

Uncertainty: Sources conflict: Printed interval (2.14-3.17) has the same log-scale width as this row's positive likelihood ratio interval and is not consistent with the Supplementary Table 6 counts; kept in printed_source_cell only.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

alignGVGD_a on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), G10; tool 'alignGVGD_a'; column 'BRCA1_negative_LR'
Configuration: alignGVGD_a (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
105 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

alignGVGD_a on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L2; tool 'alignGVGD_a'; column 'BRCA1_FN'
Configuration: alignGVGD_a (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
7.05 likelihood-ratio
unitless · higher

Uncertainty: CI 5.79 to 8.59. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

alignGVGD_a on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F10; tool 'alignGVGD_a'; column 'BRCA1_positive_LR'
Configuration: alignGVGD_b (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
2.44 benignity-likelihood-ratio
unitless · higher

Uncertainty: Sources conflict: Printed interval (2.02-2.96) has the same log-scale width as this row's positive likelihood ratio interval and is not consistent with the Supplementary Table 6 counts; kept in printed_source_cell only.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

alignGVGD_b on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), G11; tool 'alignGVGD_b'; column 'BRCA1_negative_LR'
Configuration: alignGVGD_b (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
125 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

alignGVGD_b on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L3; tool 'alignGVGD_b'; column 'BRCA1_FN'
Configuration: alignGVGD_b (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
6.67 likelihood-ratio
unitless · higher

Uncertainty: CI 5.51 to 8.08. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

alignGVGD_b on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F11; tool 'alignGVGD_b'; column 'BRCA1_positive_LR'
Configuration: BayesDEL_MaxAF_genespecific (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
17.2 benignity-likelihood-ratio
unitless · higher

Uncertainty: Sources conflict: Printed interval (16.9-17.5) has the same log-scale width as this row's positive likelihood ratio interval and is not consistent with the Supplementary Table 6 counts; kept in printed_source_cell only.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_MaxAF_genespecific on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), G50; tool 'BayesDEL_MaxAF_genespecific'; column 'BRCA1_negative_LR'
Configuration: BayesDEL_MaxAF_genespecific (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
2 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_MaxAF_genespecific on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L4; tool 'BayesDEL_MaxAF_genespecific'; column 'BRCA1_FN'
Configuration: BayesDEL_MaxAF_genespecific (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
1.09 likelihood-ratio
unitless · higher

Uncertainty: CI 1.07 to 1.11. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_MaxAF_genespecific on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F50; tool 'BayesDEL_MaxAF_genespecific'; column 'BRCA1_positive_LR'
Configuration: BayesDEL_MaxAF_universal (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
15.9 benignity-likelihood-ratio
unitless · higher

Uncertainty: Sources conflict: Printed interval (15.6-16.2) has the same log-scale width as this row's positive likelihood ratio interval and is not consistent with the Supplementary Table 6 counts; kept in printed_source_cell only.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_MaxAF_universal on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), G52; tool 'BayesDEL_MaxAF_universal'; column 'BRCA1_negative_LR'
Configuration: BayesDEL_MaxAF_universal (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
2 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_MaxAF_universal on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L5; tool 'BayesDEL_MaxAF_universal'; column 'BRCA1_FN'
Configuration: BayesDEL_MaxAF_universal (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
1.08 likelihood-ratio
unitless · higher

Uncertainty: CI 1.06 to 1.10. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_MaxAF_universal on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F52; tool 'BayesDEL_MaxAF_universal'; column 'BRCA1_positive_LR'
Configuration: BayesDEL_NoMaxAF_genespecific (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
10.8 benignity-likelihood-ratio
unitless · higher

Uncertainty: Sources conflict: Printed interval (10.4-11.1) has the same log-scale width as this row's positive likelihood ratio interval and is not consistent with the Supplementary Table 6 counts; kept in printed_source_cell only.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_NoMaxAF_genespecific on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), G37; tool 'BayesDEL_NoMaxAF_genespecific'; column 'BRCA1_negative_LR'
Configuration: BayesDEL_NoMaxAF_genespecific (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
7 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_NoMaxAF_genespecific on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L6; tool 'BayesDEL_NoMaxAF_genespecific'; column 'BRCA1_FN'
Configuration: BayesDEL_NoMaxAF_genespecific (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
1.23 likelihood-ratio
unitless · higher

Uncertainty: CI 1.19 to 1.27. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_NoMaxAF_genespecific on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F37; tool 'BayesDEL_NoMaxAF_genespecific'; column 'BRCA1_positive_LR'
Configuration: BayesDEL_NoMaxAF_universal (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
11.8 benignity-likelihood-ratio
unitless · higher

Uncertainty: Sources conflict: Printed interval (11.5-12.2) has the same log-scale width as this row's positive likelihood ratio interval and is not consistent with the Supplementary Table 6 counts; kept in printed_source_cell only.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_NoMaxAF_universal on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), G38; tool 'BayesDEL_NoMaxAF_universal'; column 'BRCA1_negative_LR'
Configuration: BayesDEL_NoMaxAF_universal (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
7 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_NoMaxAF_universal on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L7; tool 'BayesDEL_NoMaxAF_universal'; column 'BRCA1_FN'
Configuration: BayesDEL_NoMaxAF_universal (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
1.26 likelihood-ratio
unitless · higher

Uncertainty: CI 1.22 to 1.30. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

BayesDEL_NoMaxAF_universal on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F38; tool 'BayesDEL_NoMaxAF_universal'; column 'BRCA1_positive_LR'
Configuration: CADD_phred_a (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
36.7 benignity-likelihood-ratio
unitless · higher

Uncertainty: Sources conflict: Printed interval (36.0-37.4) has the same log-scale width as this row's positive likelihood ratio interval and is not consistent with the Supplementary Table 6 counts; kept in printed_source_cell only.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CADD_phred_a on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), G47; tool 'CADD_phred_a'; column 'BRCA1_negative_LR'
Configuration: CADD_phred_a (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
1 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CADD_phred_a on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L8; tool 'CADD_phred_a'; column 'BRCA1_FN'
Configuration: CADD_phred_a (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
1.1 likelihood-ratio
unitless · higher

Uncertainty: CI 1.08 to 1.12. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CADD_phred_a on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F47; tool 'CADD_phred_a'; column 'BRCA1_positive_LR'
Configuration: CADD_phred_b (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
0 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CADD_phred_b on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L9; tool 'CADD_phred_b'; column 'BRCA1_FN'
Configuration: CADD_phred_b (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
1.03 likelihood-ratio
unitless · higher

Uncertainty: CI 1.02 to 1.05. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CADD_phred_b on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F60; tool 'CADD_phred_b'; column 'BRCA1_positive_LR'
Configuration: CHASM (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
0 false-negative-count
count · lower

Uncertainty: Not applicable: Count

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CHASM on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 6 (sheet 'SupTable6_Tool_Counts'), L10; tool 'CHASM'; column 'BRCA1_FN'
Configuration: CHASM (Cubuk et al. 2021)Protocol: BRCA1 functional truth set, binary in silico calls (Cubuk et al. 2021)
Dataset: BRCA1 functional truth set: 1641 missense variants classed deleterious or tolerated by HAP1 cell survival after saturation genome editing
1 likelihood-ratio
unitless · higher

Uncertainty: CI 1 to 1. Interval level and method not printed.

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CHASM on the BRCA1 functional truth set (Cubuk et al. 2021)

brca-20261009-protocol-cubuk2021-brca1

Aggregation: Not reported

Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes; Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx) · Supplementary Table 9 (sheet 'SupTable9_Likelihood_Ratios'), F64; tool 'CHASM'; column 'BRCA1_positive_LR'

Source checking is not independent reproduction. Release 2026-10-10-84341e0b121f.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

14 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-10-84341e0b121f
Property and statementOriginal source and locationReview and provenance
attributes.assay
HAP1 cell survival after saturation genome editing (Findlay et al. 2018)
Context-only references
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Genetics in Medicine 23(11):2096, published 2021-07-06; PMC8553612 full-text XML
Retrieved: 2026-10-09T21:18:04Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: ea6391e04f5f01353bb611fd45437f21c531848cf3e93b288bdc52494efc90ae

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.assay
HAP1 cell survival after saturation genome editing (Findlay et al. 2018)
Context-only references
Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx)

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41436_2021_1265_MOESM3_ESM.xlsx
Retrieved: 2026-10-09T21:18:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 02df1b0dbf916d598dd8278ba45091022bf78c5722ac13a07d5b1b70d64dc179

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.denominator
1641
Context-only references
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Genetics in Medicine 23(11):2096, published 2021-07-06; PMC8553612 full-text XML
Retrieved: 2026-10-09T21:18:04Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.denominator

Source artifact SHA-256: ea6391e04f5f01353bb611fd45437f21c531848cf3e93b288bdc52494efc90ae

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.denominator
1641
Context-only references
Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx)

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41436_2021_1265_MOESM3_ESM.xlsx
Retrieved: 2026-10-09T21:18:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.denominator

Source artifact SHA-256: 02df1b0dbf916d598dd8278ba45091022bf78c5722ac13a07d5b1b70d64dc179

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.population
1641 missense variants (371 deleterious, 1270 tolerated) in 13 exons covering the RING and BRCT domains; start gain or loss, nonsense, splice-region flanking and intermediate or conflicting variants excluded
Context-only references
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Genetics in Medicine 23(11):2096, published 2021-07-06; PMC8553612 full-text XML
Retrieved: 2026-10-09T21:18:04Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: ea6391e04f5f01353bb611fd45437f21c531848cf3e93b288bdc52494efc90ae

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.population
1641 missense variants (371 deleterious, 1270 tolerated) in 13 exons covering the RING and BRCT domains; start gain or loss, nonsense, splice-region flanking and intermediate or conflicting variants excluded
Context-only references
Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx)

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41436_2021_1265_MOESM3_ESM.xlsx
Retrieved: 2026-10-09T21:18:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 02df1b0dbf916d598dd8278ba45091022bf78c5722ac13a07d5b1b70d64dc179

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.source_locator
Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'
Context-only references
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Genetics in Medicine 23(11):2096, published 2021-07-06; PMC8553612 full-text XML
Retrieved: 2026-10-09T21:18:04Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: ea6391e04f5f01353bb611fd45437f21c531848cf3e93b288bdc52494efc90ae

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.source_locator
Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'
Context-only references
Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx)

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41436_2021_1265_MOESM3_ESM.xlsx
Retrieved: 2026-10-09T21:18:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 02df1b0dbf916d598dd8278ba45091022bf78c5722ac13a07d5b1b70d64dc179

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.split
Whole truth set; no training
Context-only references
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Genetics in Medicine 23(11):2096, published 2021-07-06; PMC8553612 full-text XML
Retrieved: 2026-10-09T21:18:04Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: ea6391e04f5f01353bb611fd45437f21c531848cf3e93b288bdc52494efc90ae

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.split
Whole truth set; no training
Context-only references
Cubuk et al. 2021, Supplementary tables 1-13 (41436_2021_1265_MOESM3_ESM.xlsx)

Original source ↗

Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41436_2021_1265_MOESM3_ESM.xlsx
Retrieved: 2026-10-09T21:18:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: 02df1b0dbf916d598dd8278ba45091022bf78c5722ac13a07d5b1b70d64dc179

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-10-10-84341e0b121f · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: brca-20261009-data-cubuk2021-brca1-functional

areas
dna-genomes
contexts
clinical_research
population
1641 missense variants (371 deleterious, 1270 tolerated) in 13 exons covering the RING and BRCT domains; start gain or loss, nonsense, splice-region flanking and intermediate or conflicting variants excluded
assay
HAP1 cell survival after saturation genome editing (Findlay et al. 2018)
split
Whole truth set; no training
denominator
1641
source locator
Supplementary Table 2 and Supplementary Table 3; Methods 'Generation of functional truth sets'
missing metadata
version: reason: unreported; note: Assay data release not stated
Related records

Suggest a correction